From 3 to 5 October, the XLI National Congress of Pharmacology took place in Palma de Mallorca, a key meeting for the scientific community dedicated to research, where the advances in pharmacological research and therapeutics made by Spanish Pharmacologists were presented.
Within the framework of the scientific program of this congress, a session was held entitled: “Novel approaches to the design, development, and delivery of medicines”. In it, the researcher Irene Rodríguez-Clemente, member of the research group of the UCLM-CSIC Associated Unit “Neurodeath”, and participant in the Research project of the Complementary Plan of “Biotechnology applied to Health”, presented the results on the use of nanoparticles as siRNA transport agents as a new therapy for glioblastoma.
The results indicate that this approach is capable of significantly reducing the cellular levels of proteins involved in the proliferation and survival mechanisms of tumor cells and transporting siRNA into the brain and spinal cord, opening a new therapeutic perspective for diseases of the nervous system.
The research is part of line of action 5 of the Complementary Plans project: “Development of nanodrugs, biodistribution, toxicity and therapeutic actions in pathology models” . The round table was moderated by professor Valentín Ceña, coordinator of the Complementary Plans project in Castilla-La Mancha.
+ info: Website.
